Aimmune's PDUFA Jitters, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]
AIMMUNE THERAPEUTICS (AIMT)
Last aimmune therapeutics earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.aimmune.com/corporate-profile
Company Research
Source: Seeking Alpha
Summary Palforzia PDUFA has not yet been announced by the FDA. Amarin gets Canadian approval. EyeGate crashed on offering. Aimmune Therapeutics, Inc. (NASDAQ: AIMT approved The FDA actions are vital for AIMT since Palforzia has the potential to become the first of its kind for treating peanut allergy and for proving the company's platform. The drug works by desensitizing children against the allergy. If approved, it may become a trailblazer for the allergy treatments which seeks to prevent a reaction instead of simply treating the aftereffects of the allergy. As a general rule, the FDA follows the lead of its advisory committee, which was largely positive in this case. However, the agency is still shying away from announcing a PDUFA date for Palforzia. Investors and analysts are closely watching developments here. While many expect that the FDA decision may come around in a short period of time, there is no certainty attached to it. In the extreme case of no FDA announcement in the mo
Show less
Read more
Impact Snapshot
Event Time:
AIMT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AIMT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AIMT alerts
High impacting AIMMUNE THERAPEUTICS news events
Weekly update
A roundup of the hottest topics